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A R T I C L E I N F O






A B S T R A C T
Background: Orthostatic hypotension (OH) is common in older adults with reported prevalence rates of 5–40%.
A direct link between OH and cognitive performance has been proposed due to impaired vascular autoregula-
tion.
Aim: To systematically assess the literature of the association between OH and cognitive performance in older
adults.
Methods: Literature search of MEDLINE, Embase, Cochrane Central Register of Controlled Trials and PsycINFO
from inception to May 2017. Studies were included if OH and cognition were assessed in subjects of mean or
median age ≥65 years. Risk of bias was assessed with the Newcastle Ottawa Scale.
Results: Of 3266 studies screened, 32 studies (22 cross-sectional; 10 longitudinal) reporting data of 28,980
individuals were included. OH prevalence ranged from 3.3% to 58%. Of the 32 studies, 18 reported an asso-
ciation between OH and worse cognitive performance and 14 reported no association. Mini Mental State
Examination (MMSE) was the most commonly used cognitive assessment tool. Studies using more than one
cognitive assessment tool were more likely to find an association between OH and worse cognition. OH was
significantly associated with a lower MMSE mean score (mean difference − 0.51 (95% CI: −0.85, −0.17,
p= 0.003)) and an increased risk of cognitive impairment (OR 1.19 (95% CI, 1.00–1.42, p= 0.048)).
Conclusions: OH is common in older populations and is associated with worse cognition expressed as lower
MMSE scores. Use of MMSE alone as a cognitive assessment tool may underestimate the association. It is yet
unclear whether the association between OH and worse cognitive performance is causative.
1. Introduction
Orthostatic hypotension (OH) is common in older adults with pre-
valence rates ranging from 6% in healthy older adults (Joseph et al.,
2017a), 15% in geriatric outpatients and up to 41% in patients with
dementia (Sonnesyn et al., 2009; Low, 2008). Current management of
OH in clinical settings is largely dependent on the presence of ortho-
static symptoms such as dizziness, fatigue, headache and blurred vision
(Joseph et al., 2017b), however a third of older adults with OH are
asymptomatic (Arbogast et al., 2009). The diagnosis of OH is important
due to its association with poor clinical outcomes in older adults, in-
cluding all cause and cardiovascular mortality (Ricci et al., 2015;
Luukinen et al., 1999; Liguori et al., 2018), impaired standing balance
(de Bruine et al., 2018) (Mol et al., 2018), increased falls (Gupta and
Lipsitz, 2007; Novak and Hajjar, 2010; Peralta et al., 2007; Mol et al.,
2018a) and impaired of Activity of Daily Living performance (Mol
et al., 2018).
Despite the high prevalence of OH in older adults with dementia
(Passant et al., 1996), there is conflicting evidence on the relationship
between OH and cognitive performance. A possible association between
OH and worse cognition is suggested by evidence of dysregulation of
cerebral blood flow in OH (Biogeau et al., 2017) and MRI changes of
silent cerebral infarcts and deep white matter lesions associated with
OH (Kario et al., 2002).
The aim of this study was to systematically review the current lit-
erature to determine the association between OH and cognition in older
adults in comparison to those without OH. Additionally, a meta-ana-
lysis was performed to provide a pooled, combined estimate of the
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association between OH and cognitive performance.
2. Methods
The protocol of the systematic review was developed in accordance
with the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines (Liberati et al., 2009) and registered with
the PROSPERO International prospective register of systematic reviews
(CRD42017078403). MEDLINE (from 1946), EMBASE (from 1974),
Cochrane Central Register of Controlled Trials (from inception) and
PsycINFO (from 1806) databases were systematically searched for
studies published until May 2017. The search strategy included the
following key words: “orthostatic hypotension”, “orthostasis”, “ortho-
static blood pressure”, “cognition”, “old”, “cognitive impairment” and
synonyms. The complete search strategy for each database is included
in Appendix A.
2.1. Study selection
Studies were managed with EndNote (Version: X8.2 Clarivate
Analytics, Philadelphia, USA). Inclusion criteria were: article published
in English; mean or median age ≥ 65 years; participants assessed for
OH by consensus definition (a decrease of at least 20 mmHg systolic
blood pressure (BP) and/or 10 mmHg diastolic BP within the first 3 min
of standing) (Freeman et al., 2011); and, assessment of cognition was
reported for cohorts with and without OH. Studies without primary
data, such as conference abstracts and reviews, were excluded. For
studies that reported mean age by cohort (for example, cohorts with
and without OH), the study was included if the mean or median age of
at least one cohort was ≥65 years.
2.2. Data extraction
Titles and abstracts were independently reviewed by two reviewers
(VTVN, RI). Disagreements were resolved by discussion with a third
reviewer (ABM, WKL, EMR). Full texts of included articles were in-
dependently assessed and data extraction performed by two reviewers
(VTVN, RI).
2.3. Study quality
The quality and risk of bias of individual studies was assessed by
two independent reviewers (VTVN, RI) using the Newcastle-Ottawa
Scale (NOS) (Lo et al., 2014). The NOS provides an assessment of the
methodological quality of case control and cohort studies with a max-
imum score of 9 points (Lo et al., 2014). All included studies were as-
sessed using three criteria: 1) selection and representativeness of the
subjects with and without OH, ascertainment of exposure, diagnosis of
OH; 2) comparability of study groups: adjustment for potential con-
founders; and 3) outcome: assessment of cognition, adequacy of dura-
tion and completeness of follow-up. Studies with a NOS score between 0
and 3 points was defined as low quality, 4 to 6 points as moderate
quality and 7 to 9 points as high quality (Hartog et al., 2017).
2.4. Meta-analysis
Meta-analyses were performed using Comprehensive Meta-analysis
(version 2.0; Biostat Inc., Engle-wood, NJ), with a random effects model
(Borenstein et al., 2010). The means and standard deviations (SD) were
used for continuous cognitive assessment scale outcomes For the di-
chotomous outcome of diagnosis of cognitive impairment, the odds
ratio (OR) for reported prevalence in the groups with and without OH
was used. Subgroup analyses were stratified by study population. Het-
erogeneity was expressed using the I2 statistic (low < 25%; mod-
erate < 50%; high > 50%). P values below 0.05 were considered sig-
nificant. An estimate of publication bias was calculated using Egger's
test for meta-analyses of ten studies or more (Egger et al., 1997).
3. Results
Of 3266 studies eligible for title and abstract screening, 117 were
eligible for full text screening and 32 studies were included in the
systematic review. Fig. 1 shows the selection process of included stu-
dies.
3.1. Systematic review
Table 1 shows the descriptive characteristics of the included studies.
The studies included a total of 28,980 individuals. Most studies (26 out
of 32) were conducted in community-dwelling older adults, three stu-
dies included hospitalised older adults and three studies were of in-
stitutionalised older adults. Seven studies focused on OH and cognition
in patients with Parkinson's Disease (PD). Most studies (27 out of 32)
measured BP intermittently rather than continuously using beat to beat
measurements. A majority (25 out of 32) of studies tested for OH using
Active Stand Test (AST): one study did not report the method of testing
(Otsuka et al., 2014) and one study performed both AST and Head Up
Tilt (HUT) (Aydin et al., 2017). Table 2 shows the details of reported
neuropsychological testing for each study. Mini Mental State Ex-
amination (MMSE) (Folstein et al., 1975) was the most frequently used
cognitive assessment scale in 21 studies. Two or more cognitive as-
sessment scales were reported in 16 studies: although the additional
assessment scales varied, these studies were more likely to report an
4127 records identified
861 duplicates removed 
3266 records screened 
3149 records excluded 
117 full text records 
assessed for eligibility 
84 full text records excluded:  
No results on OH and/or 
cognition (n=67) 
Full text not available (n=7) 
Mean/median age <65 years 
(n=8) 
Article not in English (n=1) 
Review (n=1)  
Cohort reported twice (n=1) 
32 studies included in 
qualitative synthesis 
16 studies included in quantitative analysis  
16 studies excluded from 
quantitative analysis: 
MMSE not reported (n=15) 
Shortened MMSE (n=1) 
Fig. 1. Selection process shown through the PRISMA flow chart.
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association between OH and worse cognition.
OH prevalence ranged from 3.3% to 58%: the highest prevalence
rates were reported in falls and syncope clinic outpatients (Schoon
et al., 2013), geriatric unit inpatients (Biogeau et al., 2017), PD (Allcock
et al., 2006; Pilleri et al., 2013; Umehara et al., 2016) and dementia
(Bengtsson-Lindberg et al., 2015); the lowest prevalence rates were
reported in healthy older controls (Idiaquez et al., 2007; Hayakawa
et al., 2015).
Of the 32 included studies, 18 reported a positive association be-
tween OH and worse cognition, based on either cognitive test score
(Otsuka et al., 2014; Aydin et al., 2017; Allcock et al., 2006; Pilleri
et al., 2013; Bengtsson-Lindberg et al., 2015; Frewen et al., 2014;
Huang et al., 2017; Centi et al., 2017; Coutaz et al., 2012; Matsubayashi
et al., 1997; Mehrabian et al., 2010; Peralta et al., 2007) or diagnosis of
dementia (Hayakawa et al., 2015; Elmstahl and Widerstrom, 2014; Kim
et al., 2012; O'Hare et al., 2017a; Sonnesyn et al., 2009; Wolters et al.,
2016a) and 14 studies reported no association (Biogeau et al., 2017;
Schoon et al., 2013; Umehara et al., 2016; Idiaquez et al., 2007;
Agnoletti et al., 2015a; Bouhanick et al., 2014; Curreri et al., 2016;
Punchick et al., 2016; Soennesyn et al., 2014; Soysal et al., 2014;
Viramo et al., 1999; Yap et al., 2014; Asensio Lafuente et al., 2011;
Feeney et al., 2016).
3.1.1. Longitudinal studies: does OH predict later cognitive impairment?
Of ten longitudinal studies, two studies reported multiple assess-
ments for OH. O'Hare et al. (O'Hare et al., 2017b) tested community
dwelling older adults for OH over 6 years and assessed cognitive status
14 years later with neuropsychological assessment and brain imaging.
Average Systolic Orthostatic Blood Pressure Response (ASOBPR), the
percentage change in systolic BP from sit to stand at 1 min post stand,
was found to be lower for those with dementia compared to those with
normal cognitive status. The odds of dementia diagnosis reduced by 9%
with each percentage point rise in ASOBPR. Soennesyn et al.
(Soennesyn et al., 2014) followed older individuals with mild-moderate
dementia over 4 years, assessing cognitive decline using MMSE score
and Clinical Dementia Rating sum of boxes (Hughes et al., 1982), and
found no association between presence of OH and cognitive decline.
Eight longitudinal studies reported only a baseline measure of OH,
with follow up of cognitive performance. The four studies that reported
a positive association between OH and worse cognition had long follow
up (3 to 25 years) and used detailed cognitive assessment scales
(Hayakawa et al., 2015; Huang et al., 2017; Elmstahl and Widerstrom,
2014; Wolters et al., 2016a), whilst the 4 longitudinal studies that did
not find a significant association between OH and cognitive impairment
(Curreri et al., 2016; Viramo et al., 1999; Yap et al., 2014; Feeney et al.,
2016) had shorter follow up (1–4 years) and used MMSE as the pre-
dominant cognitive assessment scale.
3.1.2. Cross-sectional studies: Is there an association between OH and
cognitive impairment?
Seven cross-sectional studies examined the association between OH
and cognitive impairment in patients with PD: five of these studies
reported an association between OH and worse cognitive performance
in areas of attention or memory on neuropsychological assessment, but
none of the studies reported an association between OH and worse
MMSE or Frontal Assessment Battery score (Allcock et al., 2006; Pilleri
et al., 2013; Umehara et al., 2016; Idiaquez et al., 2007; Centi et al.,
2017; Peralta et al., 2007; Kim et al., 2012; Dubois et al., 2000).
Of the fifteen remaining cross-sectional studies, eight reported an
association between OH and worse cognitive performance. Studies re-
porting a positive association between OH and worse cognition were
more likely to use additional cognitive assessment scales to the MMSE
and to be prospective (Otsuka et al., 2014; Aydin et al., 2017;
Bengtsson-Lindberg et al., 2015; Coutaz et al., 2012; Matsubayashi
et al., 1997; Mehrabian et al., 2010; Sonnesyn et al., 2009; Frewen
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assess cognition using MMSE alone and to be retrospective (Biogeau
et al., 2017; Schoon et al., 2013; Bouhanick et al., 2014; Punchick et al.,
2016; Soysal et al., 2014; Asensio Lafuente et al., 2011; Agnoletti et al.,
2015b).
3.2. Quality assessment
Table 3 presents the risk of bias quality assessment for included
studies based on the Newcastle-Ottawa Scale (see Supplementary Ap-
pendix B). Eight studies were found to be of high quality, 21 studies of
moderate quality and three studies of low quality.
3.3. Meta-analysis
Meta-analysis was performed on the 16 studies that reported mean
MMSE scores for those with and without OH. Fig. 2 shows that OH was
significantly associated with a lower mean MMSE score, difference
−0.51 (95% CI: −0.85, −0.17, p= 0.003), with high heterogeneity
(I2 = 64.9%). Egger's regression test for OH and MMSE score did not
suggest publication bias (p= 0.31). Fig. 3 shows the results of the meta-
analysis of the association between OH and mean MMSE scores strati-
fied for study population. Community dwelling older adults with OH
were found to have significantly lower average MMSE mean scores in
comparison to those without OH (difference (95% CI): −0.38, (−0.71,
−0.06), p < 0.02), with moderate heterogeneity (I2 = 42.9%). No
significant differences were found for geriatric outpatients, hospitalised
patients, patients with PD or institutionalised older adults. Fig. 4 shows
the forest plot of longitudinal studies reporting odds ratios for cognitive
impairment in populations with OH compared to those without OH.
There was an association between OH and cognitive impairment in
older adults on longitudinal data [OR (95% CI): 1.19 (1.00, 1.42),
p= 0.048], with high heterogeneity (I2 = 58.9%).
4. Discussion
OH is significantly associated with a lower MMSE mean score and
higher prevalence of cognitive impairment. Cognition was assessed
with a wide range of assessment scales and cognitive outcomes were
reported heterogeneously. Most studies reporting a significant asso-
ciation between OH and worse cognition assessed cognition using
Table 2
Summary of cognitive assessment tools and results stratified for presence of OH
(n= 22).
First author, year Cognitive test(s) OH-positive OH-negative
Agnoletti 2015 MMSE, score 23.2 ± 4.9 23.4 ± 5.1









































MMSE, score 22.5 ± 5.1 24.8 ± 4.8
Biogeau 2017 MMSE, score 21.9 ± 1 23.2 ± 1.1
Bouhanick (2014) MMSE score ≤24 (%) 24.1 23.9






Coutaz 2011 MMSE, score 24.0 ± 5.5 25.6 ± 4.4
Curreri 2016 MMSE, score 27.1 ± 1.7 27.3 ± 1.8
Enrique Asensio
2011
MMSE, score 15.5 ± 7.2 16.1 ± 7.9




Color Trail 1 (seconds),
median [IQR]







































Huang, 2017 MMSE, score 26.4 ± 1.26 26.8 ± 1.09









Mehrabian, 2010 CEP, score 50 ± 24 56 ± 22
























































First author, year Cognitive test(s) OH-positive OH-negative














Soysal 2014 MMSE, score 21.0 ± 6.0 21.5 ± 6.1






Viramo 1999 Short MMSE (total
score 25), score
21.6 ± 4 21.2 ± 4.1
Yap 2008 MMSE, score 26.7 ± 3.5 27.3 ± 3.2
All variables are presented as mean (SD) unless indicated otherwise. Ms.: metres
per seconds. OH: Orthostatic hypotension. MMSE: Mini Mental State
Examination. SRT: Simple reaction time. CRT: Choice reaction time. HUT: Head
Up Tilt. AST: Active Standing Test. COST: Cognitive State Test. WTAR: Wechsler
Test of Adult Reading. MoCA: Montreal Cognitive Assessment. SART: Sustained
Attention to Response Task. HDSR: Hasegawa Dementia Scale Revised. VCPS:
Visuospatial Cognitive Performance Score. CEP: Cognitive Efficiency Profile.
FAB: Frontal Assessment Battery. TMT: Trail Making Test. ROCF: Rey-
Osterrieth Complex Figure. CAMCOG: Cognitive and self-contained part of the
Cambridge Examination for Mental Disorders of the Elderly. CDR-SB: Clinical
Dementia Rating Sum of Boxes. sMMSE: shortened Mini Mental State
Examination.
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multiple cognitive assessment scales or reported diagnosis of dementia.
MMSE was originally developed to quickly assess and grade cogni-
tion (Folstein et al., 1975), however it has limitations, including poor
identification of executive dysfunction (Allone et al., 2018); floor ef-
fects in patients with limited education or advanced dementia; ceiling
effect for those with mild cognitive impairment; and, the possibility of
Table 3
Risk of bias quality assessment (using Newcastle-Ottawa Scale).
First author,
year




















Agnoletti 2015 + + − + − + − − 4 Moderate
Allcock 2006 + − − − − + − − 2 Low




+ + − + − + − − 4 Moderate
Biogeau 2017 + + − + − + − − 4 Moderate
Bouhanick 2014 + + − + − + − − 4 Moderate
Centi 2017 + + + + − + − − 5 Moderate
Coutaz 2011 + + − + − + − − 4 Moderate
Curreri 2016 + + − + ++ + + − 7 High
Enrique Asensio
2011
+ + − + − + − − 4 Moderate
Elmstahl 2014 + + − − − + + − 4 Moderate
Feeney 2016 + + + − ++ + + − 7 High
Frewen 2014 + + − − − + − − 3 Low
Huang 2017 + + − + − + + + 6 Moderate
Idiaquez 2007 + + + + − + − − 5 Moderate
Kim 2012 + + − + − + − − 4 Moderate
Matsubayashi
1997
+ + − + − + − − 4 Moderate
Mehrabian 2010 + + − + ++ + − − 6 Moderate
O'Hare 2017 + + − + ++ + + + 8 High
Otsuka 2014 + + − − − + − − 3 Low
Peralta 2007 + + + + ++ + − − 7 High
Pilleri 2013 + + − + − + − − 4 Moderate
Punchick 2016 + + − + − + − − 4 Moderate
Schoon 2013 + + + − − + − − 4 Moderate
Soennesyn 2014 + + − + ++ + + + 8 High
Sonnesyn 2009 + + − + ++ + − − 6 Moderate
Soysal 2014 + + − + − + − − 4 Moderate
Struhal 2014 + + + + − + − − 5 Moderate
Umehara 2016 + + − + + + − − 5 Moderate
Viramo 1999 + + − + ++ + + − 7 High
Wolters 2016 + + − + ++ + + − 7 High
Yap 2008 + + − + ++ + + + 8 High
+ quality criterion met; − quality criterion not met. Study with score between 0 and 3 is considered of low quality, 4–6 as moderate quality, 7–9 as high quality. OH:
orthostatic hypotension.
Favours lower MMSE Favours higher MMSE
Fig. 2. Meta-analysis showing the pooled estimate on the overall association between OH and MMSE scores. CI: confidence intervals. I2 = 64.9%.
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learning effects with repeated use (Houx et al., 2002) (Devenney and
Hodges, 2017). A recent meta-analysis indicated that MMSE may be
most useful for ruling out cognitive impairment in the community
setting, and that in other settings it should be used in combination with
other assessment tools (Mitchell, 2009). Therefore, it is possible that the
use of MMSE as a measure underestimates the magnitude of the asso-
ciation between OH and cognition.
This systematic review confirmed high prevalence rates of OH in
older adults, particularly in geriatric outpatients, PD and dementia.
This is consistent with a recent study demonstrating higher rates of OH
among frail older adults (Liguori et al., 2018). Bengtsson-Lindberg et al.
reported that nearly two thirds of participants with OH and dementia
did not have OH symptoms (Bengtsson-Lindberg et al., 2015). This
highlights the importance of assessing older patients for OH, particu-
larly those with dementia, regardless of symptomatology.
4.1. Potential mechanisms for the association between OH and worse
cognition
The findings of this systematic review and meta-analysis do not
prove a causal association between OH and worse cognition, however,
we postulate that changes in cerebral perfusion in OH may lead to
cognitive decline. During rapid changes in systemic blood pressure,
cerebral perfusion is maintained by cerebral autoregulation, particu-
larly dynamic cerebral autoregulation (Novak and Hajjar, 2010; Poda
et al., 2012). Studies of cerebral blood flow (CBF) during upright tilt
have identified reduced CBF in frontal regions in OH in both healthy
elderly and patients with Alzheimer's type dementia (Siennicki-Lantz
et al., 1999). Also, rapid changes in systolic blood pressure has been
associated with worse physical performance (Mol et al., 2018b). The
studies by Centi et al. and Peralta et al. reporting an association be-
tween worse cognitive performance in patients with OH and PD during
upright tilt (compared to supine), support the hypothesis that cerebral
blood flow change in OH can affect cognition (Centi et al., 2017; Peralta
et al., 2007). Mortality rates are higher in older patients with both low
and high diastolic blood pressure, and this is more marked in cogni-
tively impaired patients (Cacciatore et al., 2005). Decrease in blood
flow to the brain may lead to formation of subcortical infarcts and
white matter hyperintensities (Centi et al., 2016). Amyloid deposition
may also be implicated: ischaemic stress is associated with amyloid
deposition in the human brain (Jendroska et al., 1995) and cerebral
hypoperfusion in rodents is associated with increased expression of ß-
amyloid precursor protein (Shi et al., 2000). It is possible, however, that
autonomic dysfunction is a marker of neurodegenerative disease that
causes both OH and cognitive change, rather than a causative factor
(Allcock et al., 2006).
4.2. Strengths and limitations
To the best of our knowledge, this is the first systematic review and
meta-analysis on the association between OH and cognition in all older
adult populations. One limitation of our review is that studies reporting
cognitive tests other than MMSE were excluded from the meta-analysis
due to the small numbers and range of tests used. Furthermore, there
was high heterogeneity in the meta-analysis of the association between
MMSE scores and OH. We were unable to perform additional age- and
sex-specific analyses due to the limited reported data. Future pooled
estimates at patient-level may provide better insights into the
Favours lower MMSE Favours higher MMSE
Fig. 3. Meta-analysis showing the association between OH and MMSE scores of studies stratified by study population. CI: confidence intervals.
Favours no associaon Favours associaon
Fig. 4. Meta-analysis showing on the association between OH and incident cognitive impairment. CI: confidence intervals. I2 = 58.9%.
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association between OH and cognition, as prevalence of OH and cog-
nitive impairment increases with age (Rutan et al., 1992).
More studies diagnosed OH using the AST, rather than HUT. Aydin
et al. found that OH diagnosed using HUT was more predictive of ad-
verse clinical outcomes than OH diagnosed by AST (Aydin et al., 2017);
therefore, the association between OH and worse cognition may have
been underestimated in this review.
5. Conclusions
Orthostatic hypotension is associated with lower MMSE scores and
increased rates of cognitive impairment. Whether the association be-
tween OH and worse cognition is causative remains uncertain, and
requires further longitudinal studies using comprehensive cognitive
assessment tools and repeated assessment for OH. OH is highly pre-
valent, especially in patients with dementia, and is often asymptomatic.
We recommend that older patients, especially those with cognitive
decline and dementia, are routinely assessed for OH.
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